Dr. Randy Hall
Randy A. Hall, Ph.D., is a Professor of Pharmacology and Chemical Biology in the Emory University School of Medicine. His laboratory's research focuses on the signaling and regulation of G protein-coupled receptors in the nervous system. Dr. Hall recently received a new NIH grant entitled “Disease-Associated Mutations and Ligand Activation of the Adhesion G Protein-Coupled Receptor ADGRB2”. This grant received a top 1% score, leading Dr. Hall to be recognized with an “Emory 1%” award from the Emory University School of Medicine.
Dr. Hall received his Bachelor's degree from the University of New Hampshire and attended graduate school at the University of California at Irvine, studying the regulation of glutamate receptors under the direction of Gary Lynch. After obtaining his Ph.D., Dr. Hall moved to the Vollum Institute in Portland, Oregon, to do a post-doctoral fellowship in the laboratory of Thomas Soderling studying glutamate receptor trafficking and phosphorylation. Later, Dr. Hall continued his post-doctoral training at Duke University, where he studied the regulation of adrenergic receptors in the laboratory of Nobel Laureate Robert Lefkowitz.
Dr. Hall has published more than 130 papers and received numerous awards for his research, including the PhRMA New Investigator Award, the Distinguished Young Scholar in Medical Research award from the W.M. Keck Foundation, and the John J. Abel Award from ASPET. In 2014, Dr. Hall was named a Fellow of the AAAS. Most recently, Dr. Hall was elected to serve at the President of the American Society for Pharmacology and Experimental Therapeutics (ASPET). After serving as President-Elect for a year, he will officially begin his term as President on July 1, 2025.